
A nurse puts a blood sample from a newborn onto a file card for a rare disease screening. (Photo by: Arno Burgi/picture-alliance/dpa/AP Images)
The Trump administration disbanded a newborn screening panel. Advocates now face a harder path
Patient groups face a harder and unpredictable path going state-by-state to boost screening for rare but treatable conditions after the Trump administration disbanded a federal …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.